Next Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJ

Next Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJ Fri, 29 Jul 2005 The Wall Street Journal uncritically reported: “The results of the largest studies ever conducted of depression and schizophrenia will be released in coming months, potentially . . . Continue reading →

Use of combinations of antipsychotics–Harms Patients: McLean & Leipzig

Use of combinations of antipsychotics–Harms Patients: McLean & Leipzig Wed, 21 Sep 2005 Two additional studies provide additional evidence (coffin nails) demonstrating how psychiatry’s marriage of convenience gave birth to rotten fruit: specifically, under the influence of pharmaceutical companies, psychiatry plunged irresponsibly . . . Continue reading →

Polypharm & New Antipsychotics Not More Beneficial-Just More Expensive

"modern pharmacological treatment may be no more beneficial than older ones, despite their added cost." Continue reading →